Fig. 3
DAA treatment cascade percentages among 4,928 HCV-Ab-positive individuals Ab, Antibody; DAA, Direct-acting antiviral; HCV, Hepatitis C virus; SVR, Sustained virological response.
Fig. 3 | Scientific Reports
DAA treatment cascade percentages among 4,928 HCV-Ab-positive individuals Ab, Antibody; DAA, Direct-acting antiviral; HCV, Hepatitis C virus; SVR, Sustained virological response.
